Abstract:Insulin resistance and pancreatic β-cell dysfunction are major pathological mechanisms implicated in the development and progression of type 2 diabetes (T2D). Beyond the detrimental effects of insulin resistance, inflammation and oxidative stress have emerged as critical features of T2D that define β-cell dysfunction. Predominant markers of inflammation such as C-reactive protein, tumor necrosis factor alpha, and interleukin-1β are consistently associated with β-cell failure in preclinical models and in people with T2D. Similarly, important markers of oxidative stress, such as increased reactive oxygen species and depleted intracellular antioxidants, are consistent with pancreatic β-cell damage in conditions of T2D. Such effects illustrate a pathological relationship between an abnormal inflammatory response and generation of oxidative stress during the progression of T2D. The current review explores preclinical and clinical research on the patho-logical implications of inflammation and oxidative stress during the development of β-cell dysfunction in T2D. Moreover, important molecular mechanisms and relevant biomarkers involved in this process are discussed to divulge a pathological link between inflammation and oxidative stress during β-cell failure in T2D. Underpinning the clinical relevance of the review, a systematic analysis of evidence from randomized controlled trials is covered, on the potential therapeutic effects of some commonly used antidiabetic agents in modulating inflammatory makers to improve β-cell function. Key Words: Type 2 diabetes, Insulin resistance, β-cell dysfunction, Inflammation, Oxidative stress Core Tip: Elevated markers of inflammation and oxidative stress are related to β-cell dysfunction, the intracellular defense (antioxidant) mechanisms responsible for ameliorating some of these effects are significantly depleted during type 2 diabetes (T2D). Thus, beyond lowering glucose levels like most antidiabetic drugs, future research should invest in developing therapeutic agents to ameliorate inflammation and oxidative stress to improve blood control in patients with T2D. Citation: Dludla PV, Mabhida SE, Ziqubu K, Nkambule BB, Mazibuko-Mbeje SE, Hanser S, Basson AK, Pheiffer C, Kengne AP. Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress. World J Diabetes 2023; 14(3): 130-146 URL: https://www.wjgnet.com/1948-9358/full/v14/i3/130.htm DOI: https://dx.doi.org/10.4239/wjd.v14.i3.130

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

The Dynamics Mechanism of Islet Inflammation During Type 2 Diabetes Progress

Inside the β Cell: Molecular Stress Response Pathways in Diabetes Pathogenesis

Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus.

Relationship Between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues

Metabolic Stress and Compromised Identity of Pancreatic Beta Cells

Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress

Pancreatic Beta-cell Dysfunction in Type 2 Diabetes

A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes

Living Dangerously: Protective and Harmful ER Stress Responses in Pancreatic β-Cells

Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

Pancreatic -cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment

Endoplasmic Reticulum (ER) Stress and Its Role in Pancreatic β-Cell Dysfunction and Senescence in Type 2 Diabetes

New Developments in T Cell Immunometabolism and Therapeutic Implications for Type 1 Diabetes

Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus

Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice

Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence